TRAVERE THERAPEUTICS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2011 | — | — | $0 |
| Dec 2011 | $555.9K | $19.6K | $10.1K |
| Feb 2012 | $67.0K | $3.9K | — |
| Mar 2012 | — | — | $1.3K |
| May 2012 | $67.5K | $3.9K | — |
| Jun 2012 | — | — | $31.4K |
| Aug 2012 | $68.0K | $3.9K | — |
| Sep 2012 | — | — | $2.2K |
| Nov 2012 | $68.7K | $3.9K | — |
| Dec 2012 | $5.8M | $2.4M | $11.0K |
| Mar 2013 | $8.5M | $5.0M | $2.5M |
| Jun 2013 | $11.1M | $2.7M | $286.5K |
| Sep 2013 | $30.9M | $21.4M | $13.4M |
| Dec 2013 | $40.2M | $20.5M | $6.0M |
| Mar 2014 | $129.4M | $94.0M | $3.7M |
| Jun 2014 | $154.5M | $155.5M | $39.9M |
| Sep 2014 | $156.1M | $145.9M | $25.9M |
| Dec 2014 | $172.7M | $135.5M | $18.2M |
| Mar 2015 | $247.4M | $416.0M | $120.2M |
| Jun 2015 | $274.4M | $425.1M | $127.7M |
| Sep 2015 | $220.6M | $511.6M | $140.6M |
| Dec 2015 | $212.3M | $512.3M | $37.8M |
| Mar 2016 | $187.9M | $507.1M | $23.3M |
| Jun 2016 | $219.6M | $534.0M | $21.2M |
| Sep 2016 | $224.8M | $532.4M | $23.9M |
| Dec 2016 | $217.5M | $525.3M | $41.0M |
| Mar 2017 | $209.4M | $510.4M | $41.9M |
| Jun 2017 | $211.3M | $507.1M | $89.3M |
| Sep 2017 | $216.0M | $520.5M | $99.0M |
| Dec 2017 | $227.2M | $520.3M | $99.4M |
| Mar 2018 | $201.3M | $500.8M | $61.1M |
| Jun 2018 | $203.2M | $491.1M | $89.3M |
| Sep 2018 | $397.1M | $716.2M | $154.8M |
| Dec 2018 | $390.9M | $709.2M | $102.9M |
| Mar 2019 | $382.0M | $667.7M | $69.8M |
| Jun 2019 | $370.5M | $647.6M | $75.7M |
| Sep 2019 | $367.9M | $613.8M | $65.2M |
| Dec 2019 | $383.6M | $604.8M | $62.4M |
| Mar 2020 | $347.3M | $573.1M | $67.0M |
| Jun 2020 | $360.0M | $678.7M | $237.2M |
| Sep 2020 | $390.8M | $692.2M | $200.5M |
| Dec 2020 | $396.2M | $607.4M | $84.8M |
| Mar 2021 | $401.4M | $764.0M | $148.2M |
| Jun 2021 | $414.5M | $746.8M | $83.3M |
| Sep 2021 | $467.7M | $775.1M | $150.3M |
| Dec 2021 | $474.5M | $776.6M | $165.8M |
| Mar 2022 | $620.3M | $828.4M | $256.6M |
| Jun 2022 | $622.8M | $779.5M | $179.8M |
| Sep 2022 | $625.5M | $726.2M | $151.3M |
| Dec 2022 | $629.7M | $672.6M | $61.7M |
| Mar 2023 | $619.1M | $808.2M | $161.4M |
| Jun 2023 | $619.9M | $736.4M | $70.9M |
| Sep 2023 | $553.1M | $832.9M | $144.2M |
| Dec 2023 | $588.1M | $788.9M | $58.2M |
| Mar 2024 | $589.5M | $663.5M | $43.3M |
| Jun 2024 | $536.0M | $551.1M | $32.3M |
| Sep 2024 | $534.9M | $504.4M | $36.4M |
| Dec 2024 | $535.0M | $594.1M | $58.5M |
| Mar 2025 | $516.0M | $548.8M | $61.9M |
| Jun 2025 | $522.6M | $555.3M | $75.2M |
| Sep 2025 | $465.0M | $538.6M | $110.9M |
| Dec 2025 | $490.4M | $605.2M | $93.0M |
| Mar 2026 | $456.5M | $555.2M | $78.4M |
| Jun 2026 | $774.8M | $799.4M | $117.7M |